Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12 USD | +1.02% | +6.58% | +57.49% |
05-13 | Baird Adjusts Price Target on Instil Bio to $32 From $54, Maintains Outperform Rating | MT |
05-10 | Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.49% | 77.27M | |
+27.89% | 49.18B | |
+0.73% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.51% | 18.71B | |
+7.97% | 13.26B | |
+32.26% | 12.32B | |
-0.34% | 11.99B |
- Stock Market
- Equities
- TIL Stock
- News Instil Bio, Inc.
- Instil Bio : Morgan Stanley Initiates Coverage on Instil Bio With Equal-Weight Rating, $24 Price Target